These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3097249)

  • 1. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
    J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.
    Oxenkrug GF; McCauley R; McIntyre IM; Filipowicz C
    J Neural Transm; 1985; 61(3-4):265-70. PubMed ID: 2580945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does moclobemide stimulate melatonin synthesis as the other selective MAO-A inhibitors do?
    Oxenkrug GF; Requintina PJ; Yuwiler A
    J Neural Transm Suppl; 1990; 32():171-5. PubMed ID: 2089086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of selective monoamine oxidase inhibitors on rat pineal melatonin synthesis in vitro.
    Oxenkrug G; McIntyre I; McCauley R; Yuwiler A
    J Pineal Res; 1988; 5(1):99-109. PubMed ID: 2452867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic effect of the irreversible and reversible selective MAO-A inhibitors on rat pineal melatonin biosynthesis.
    Oxenkrug GF; Requintina PJ; McIntyre IM; White K
    J Neural Transm Suppl; 1994; 41():381-4. PubMed ID: 7523585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of MAO-A inhibition and cold-immobilization stress on N-acetylserotonin and melatonin in SHR and WKY rats.
    Oxenkrug GF; Requintina PJ
    J Neural Transm Suppl; 1998; 52():333-6. PubMed ID: 9564635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [N-acetylserotonin and hypotensive effect of MAO-A inhibitors].
    Oxenkrug GF
    Vopr Med Khim; 1997; 43(6):522-6. PubMed ID: 9503569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of rat pineal melatonin synthesis: effect of monoamine oxidase inhibition.
    King TS; Richardson BA; Reiter RJ
    Mol Cell Endocrinol; 1982 Mar; 25(3):327-38. PubMed ID: 6279462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical sympathectomy and clorgyline-induced stimulation of rat pineal melatonin synthesis.
    Reuss S; Oxenkrug GF
    J Neural Transm; 1989; 78(2):167-72. PubMed ID: 2478663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The response of the pineal melatonin biosynthesis to the selective MAO-A inhibitor, clorgyline, in young and middle-aged rats.
    Oxenkrug GF; McIntyre IM; Requintina PJ; Duffy JD
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):895-902. PubMed ID: 1722343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I; Youdim MB; Finberg JP
    J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM; Masini-Repiso AM; Costamagna ME; Pellizas C; Coleoni AH
    J Endocrinol; 1994 Nov; 143(2):303-8. PubMed ID: 7829993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of superior cervical ganglionectomy on melatonin stimulation by specific MAO-A inhibition.
    McIntyre IM; McCauley R; Murphy S; Goldman H; Oxenkrug GF
    Biochem Pharmacol; 1985 Sep; 34(18):3393-4. PubMed ID: 2412565
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of 6-months l-deprenyl administration on pineal MAO-A and MAO-B activity and on the content of melatonin and related indoles in aged female Fisher 344N rats.
    Oxenkrug GF; Requintina PJ; Correa RM; Yuwiler A
    J Neural Transm Suppl; 1994; 41():249-52. PubMed ID: 7931233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA; Medvedev AE
    Med Sci Monit; 2001; 7(1):17-9. PubMed ID: 11208486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.